12,000
Participants
Start Date
February 1, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
participants will undergo dual-energy CT and endoscopy
Diagnostic Test: P85-Ab,EBNA1-IgA,and VCA-IgA. Detect P85-Ab, EBNA1-IgA, VCA-IgA for all participants and select serological high-risk participants DiagnosticTest: dual-energy CT, endoscopy and biopsy. serological high-risk participants will refer to dual-energy CT, endoscopy and biospy
RECRUITING
Zhongshan People's Hospital, Zhongshan
Zhongshan People's Hospital, Guangdong, China
OTHER